Loading...
Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer
Xie, Yumei ; Aillon, Kristin L. ; Cai, Shuang ; Christian, Jason M. ; Davies, Neal M. ; Berkland, Cory J. ; Forrest, M. Laird
Xie, Yumei
Aillon, Kristin L.
Cai, Shuang
Christian, Jason M.
Davies, Neal M.
Berkland, Cory J.
Forrest, M. Laird
Citations
Altmetric:
Abstract
Cisplatin (CDDP) intravenous treatments suffer several dose-limiting toxicity issues. Hyaluronan (HA), a naturally occurring biopolymer in the interstitium, is primarily cleared by the lymphatic system. An alteration in input rate and administration route through pulmonary delivery of hyaluronan-cisplatin conjugate (HA-Pt) may increase local lung CDDP concentrations and decrease systemic toxicity.
Sprague-Dawley rats were split into four groups: i.v. CDDP (3.5 mg/kg), i.v. HA-Pt conjugate (3.5 mg/kg equivalent CDDP), lung instillation CDDP and lung instillation HA-Pt conjugate. Total platinum level in the lungs of the HA-Pt lung instillation group was 5.7-fold and 1.2-fold higher than the CDDP intravenous group at 24 h and 96 h, respectively. A 1.1-fold increase of Pt accumulation in lung draining nodes for the HA-Pt lung instillation group was achieved at 24 h relative to the CDDP i.v. group. In the brain and kidneys, the CDDP i.v. group had higher tissue/plasma ratios compared to the HA-Pt lung instillation group. Augmented tissue distribution from CDDP i.v. could translate into enhanced tissue toxicity compared to the altered input rate and distribution of the intrapulmonary nanoformulation.
In conclusion, a local pulmonary CDDP delivery system was developed with increased platinum concentration in the lungs and draining nodes compared to i.v. therapy.
Description
Date
2011-06-15
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Collections
Files
Loading...
berkland_pulmonary.pdf
Adobe PDF, 1.38 MB
Research Projects
Organizational Units
Journal Issue
Keywords
Cisplatin, Hyaluronan, Pharmacokinetics, Pulmonary delivery, Lung chemotherapeutics
Citation
Xie, Yumei, Kristin L. Aillon, Shuang Cai, Jason M. Christian, Neal M. Davies, Cory J. Berkland, and M. Laird Forrest. "Pulmonary Delivery of Cisplatin-hyaluronan Conjugates via Endotracheal Instillation for the Treatment of Lung Cancer." International Journal of Pharmaceutics 392.1-2 (2010): 156-63.
